Recent Publications

Ascierto P, Munn D, Palucka AK, Sondel PM. Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer. J Immunother Cancer. 2014;2:15-28.

Capitini CM, Nasholm NM, Chien CD, Larabee SM, Qin H, Song YK, Klover PJ, Hennighausen L, Khan J, Fry TJ. Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD. Blood. 2014 Sep 18;124(12):1976-86. Epub 2014 Jul 25. PMID: 25079358.

Capitini CM, Otto M, DeSantes KB, Sondel PM. Immunotherapy in pediatric malignancies: current status and future perspectives. Future Oncol. 2014;10(9):1659-78. PMID: 25145434.

Navid F, Sondel PM, Barfield R, Shulkin BL, Kaufman RA, Allay JA, Gan J, Hutson P, Seo S, Kim K, Goldberg J, Hank JA, Billups CA, Wu J, Furman WL, McGregor LM, Otto M, Gillies SD, Handgretinger R, Santana VM. Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma. J Clin Oncol. 2014 May 10;32(14):1445-52. Epub 2014 Apr 7. PMID: 24711551.

Sheridan RT, Hudon J, Hank JA, Sondel PM, Kiessling LL. Rhamnose glycoconjugates for the recruitment of endogenous anti-carbohydrate antibodies to tumor cells. Chembiochem. 2014 Jul 7;15(10):1393-8. Epub 2014 Jun 6. PMID: 24909955.

Wolfe AD, Frierdich SA, Wish J, Kilgore-Carlin J, Plotkin JA, Hoover-Regan M. Sharing life-altering information: development of pediatric hospital guidelines and team training. J Palliat Med. 2014 Sep;17(9):1011-8. Epub 2014 Jun 27. PMID: 24971650.

Xu Y, Baiu DC, Sherwood JA, McElreath MR, Qin Y, Lackey KH, Otto M, Bao Y. Linker-free conjugation and specific cell targeting of antibody functionalized iron-oxide nanoparticles. J Mater Chem. 2014;2(37):6198-6206.